A novel WT1 gene mutation in a chinese girl with denys-drash syndrome

Objective: Denys-Drash syndrome (DDS) is defined by the triad of Wilms tumor, nephrotic syndrome, and/or ambiguous genitalia. Genetic testing may help identify new gene mutation sites and play an important role in clinical decision-making. Methods: We present a patient with an XY karyotype and femal...

Full description

Bibliographic Details
Main Authors: Cai, J. (Author), Guan, Z. (Author), He, M. (Author), Jin, H. (Author), Li, L. (Author), Mao, J. (Author), Shu, Q. (Author), Wang, F. (Author), Wang, J. (Author), Zhao, M. (Author), Zhu, K. (Author)
Format: Article
Language:English
Published: John Wiley and Sons Inc 2021
Subjects:
46
Online Access:View Fulltext in Publisher
LEADER 05040nam a2201429Ia 4500
001 10.1002-jcla.23769
008 220427s2021 CNT 000 0 und d
020 |a 08878013 (ISSN) 
245 1 0 |a A novel WT1 gene mutation in a chinese girl with denys-drash syndrome 
260 0 |b John Wiley and Sons Inc  |c 2021 
856 |z View Fulltext in Publisher  |u https://doi.org/10.1002/jcla.23769 
520 3 |a Objective: Denys-Drash syndrome (DDS) is defined by the triad of Wilms tumor, nephrotic syndrome, and/or ambiguous genitalia. Genetic testing may help identify new gene mutation sites and play an important role in clinical decision-making. Methods: We present a patient with an XY karyotype and female appearance, nephropathy, and Wilms tumor in the right kidney. Genomic DNA was extracted from peripheral blood cells according to standard protocols. “Next-generation” sequencing (NGS) was performed to identify novel variants. The variant was analyzed with Mutation Taster, and its function was explored by a cell growth inhibition assay. Results: We found the first case of Denys-Drash syndrome with the uncommon missense mutation (c.1420C>T, p.His474 Tyr) in the WT1 gene. In silico analysis, the variant was predicted “disease-causing” by Mutation Taster. The mutated variant showed a weaker effect in inhibiting tumor cells than wild-type WT1. Conclusions: The uncommon missense mutation (c.1420C>T, p.His474 Tyr) in the WT1 gene may be a crucial marker in DDS. © 2021 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC 
650 0 4 |a 46 
650 0 4 |a abdominal mass 
650 0 4 |a abdominal radiography 
650 0 4 |a albumin 
650 0 4 |a albumin blood level 
650 0 4 |a amino acid sequence 
650 0 4 |a Amino Acid Sequence 
650 0 4 |a antineoplastic agent 
650 0 4 |a Article 
650 0 4 |a Asian continental ancestry group 
650 0 4 |a Asian Continental Ancestry Group 
650 0 4 |a B scan 
650 0 4 |a Base Sequence 
650 0 4 |a CA 19-9 antigen 
650 0 4 |a carcinoembryonic antigen 
650 0 4 |a carcinogenesis 
650 0 4 |a case report 
650 0 4 |a Cell Line, Tumor 
650 0 4 |a cell viability 
650 0 4 |a chemistry 
650 0 4 |a child 
650 0 4 |a China 
650 0 4 |a China 
650 0 4 |a Chinese 
650 0 4 |a clinical article 
650 0 4 |a clinical examination 
650 0 4 |a clitoris hypertrophy 
650 0 4 |a complementary DNA 
650 0 4 |a computer assisted tomography 
650 0 4 |a computer simulation 
650 0 4 |a Computer Simulation 
650 0 4 |a contrast enhancement 
650 0 4 |a Denys Drash syndrome 
650 0 4 |a Denys Drash syndrome 
650 0 4 |a Denys-Drash Syndrome 
650 0 4 |a Denys-Drash syndrome (DDS) 
650 0 4 |a diagnostic imaging 
650 0 4 |a disease severity 
650 0 4 |a DNA extraction 
650 0 4 |a DNA sequence 
650 0 4 |a electrocardiogram 
650 0 4 |a enalapril maleate 
650 0 4 |a exon 
650 0 4 |a female 
650 0 4 |a Female 
650 0 4 |a follow up 
650 0 4 |a Follow-Up Studies 
650 0 4 |a genetic screening 
650 0 4 |a genetics 
650 0 4 |a genomic DNA 
650 0 4 |a heterozygosity 
650 0 4 |a high throughput sequencing 
650 0 4 |a histopathology 
650 0 4 |a human 
650 0 4 |a human tissue 
650 0 4 |a Humans 
650 0 4 |a hypertension 
650 0 4 |a image analysis 
650 0 4 |a indel mutation 
650 0 4 |a infant 
650 0 4 |a Infant 
650 0 4 |a karyotype 
650 0 4 |a kidney biopsy 
650 0 4 |a kidney disease 
650 0 4 |a laboratory test 
650 0 4 |a laparoscopy 
650 0 4 |a Laparoscopy 
650 0 4 |a large core needle biopsy 
650 0 4 |a microalbuminuria 
650 0 4 |a missense mutation 
650 0 4 |a mutation 
650 0 4 |a Mutation 
650 0 4 |a nephrectomy 
650 0 4 |a nephroblastoma 
650 0 4 |a nephroblastoma 
650 0 4 |a nephrotic syndrome 
650 0 4 |a nucleotide sequence 
650 0 4 |a pedigree 
650 0 4 |a Pedigree 
650 0 4 |a physical examination 
650 0 4 |a preschool child 
650 0 4 |a RNA extraction 
650 0 4 |a Sanger sequencing 
650 0 4 |a sequence alignment 
650 0 4 |a single nucleotide polymorphism 
650 0 4 |a Tomography, X-Ray Computed 
650 0 4 |a tumor cell line 
650 0 4 |a valsartan 
650 0 4 |a Wilms tumor 
650 0 4 |a Wilms Tumor 
650 0 4 |a Wilms tumor-1 (WT1) 
650 0 4 |a WT1 gene 
650 0 4 |a WT1 protein 
650 0 4 |a WT1 protein 
650 0 4 |a WT1 protein, human 
650 0 4 |a WT1 Proteins 
650 0 4 |a x-ray computed tomography 
650 0 4 |a XY karyotype 
700 1 |a Cai, J.  |e author 
700 1 |a Guan, Z.  |e author 
700 1 |a He, M.  |e author 
700 1 |a Jin, H.  |e author 
700 1 |a Li, L.  |e author 
700 1 |a Mao, J.  |e author 
700 1 |a Shu, Q.  |e author 
700 1 |a Wang, F.  |e author 
700 1 |a Wang, J.  |e author 
700 1 |a Zhao, M.  |e author 
700 1 |a Zhu, K.  |e author 
773 |t Journal of Clinical Laboratory Analysis